BioLife Solutions, Inc. (BLFS)
34.95
+0.03
(+0.09%)
USD |
NASDAQ |
Sep 11, 16:00
34.93
-0.02
(-0.06%)
After-Hours: 20:00
BioLife Solutions Market Cap : 1.709B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.709B |
| September 10, 2026 | 1.707B |
| September 09, 2026 | 1.708B |
| September 08, 2026 | 1.730B |
| September 04, 2026 | 1.723B |
| September 03, 2026 | 1.737B |
| September 02, 2026 | 1.756B |
| September 01, 2026 | 1.734B |
| August 31, 2026 | 1.812B |
| August 28, 2026 | 1.779B |
| August 27, 2026 | 1.819B |
| August 26, 2026 | 1.809B |
| August 25, 2026 | 1.820B |
| August 24, 2026 | 1.818B |
| August 21, 2026 | 1.814B |
| August 20, 2026 | 1.807B |
| August 19, 2026 | 1.783B |
| August 18, 2026 | 1.708B |
| August 17, 2026 | 1.733B |
| August 14, 2026 | 1.715B |
| August 13, 2026 | 1.722B |
| August 12, 2026 | 1.710B |
| August 11, 2026 | 1.702B |
| August 10, 2026 | 1.694B |
| August 07, 2026 | 1.694B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.659B |
| August 05, 2026 | 1.652B |
| August 04, 2026 | 1.590B |
| August 03, 2026 | 1.570B |
| July 31, 2026 | 1.527B |
| July 30, 2026 | 1.545B |
| July 29, 2026 | 1.538B |
| July 28, 2026 | 1.561B |
| July 27, 2026 | 1.455B |
| July 24, 2026 | 1.464B |
| July 23, 2026 | 1.502B |
| July 22, 2026 | 1.521B |
| July 21, 2026 | 1.425B |
| July 20, 2026 | 1.420B |
| July 17, 2026 | 1.423B |
| July 16, 2026 | 1.477B |
| July 15, 2026 | 1.423B |
| July 14, 2026 | 1.399B |
| July 13, 2026 | 1.372B |
| July 10, 2026 | 1.376B |
| July 09, 2026 | 1.378B |
| July 08, 2026 | 1.328B |
| July 07, 2026 | 1.364B |
| July 06, 2026 | 1.357B |
| July 02, 2026 | 1.372B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Repligen Corp. | 9.321B |
| Agilent Technologies, Inc. | 41.43B |
| Danaher Corp. | 140.68B |
| Thermo Fisher Scientific, Inc. | 225.48B |
| West Pharmaceutical Services, Inc. | 24.37B |
Market Cap Related Metrics
| PE Ratio | 36.14 |
| PS Ratio | 16.68 |
| Price to Book Value | 4.068 |
| Price to Free Cash Flow | 214.72 |
| Price | 34.95 |
| Earnings Yield | 2.77% |
| Operating PE Ratio | 575.30 |
| Normalized PE Ratio | 36.14 |